Measurement of self-reported HIV risk behaviors in injection drug users: Comparison of standard versus timeline follow-back administration procedures

Alcohol and Drug Abuse Treatment Program at McLean Hospital, Belmont, MA 02478, USA.
Journal of substance abuse treatment (Impact Factor: 2.9). 09/2009; 38(1):60-5. DOI: 10.1016/j.jsat.2009.06.004
Source: PubMed


This study compares the frequencies of retrospective self-reported HIV high-risk drug use and sexual behaviors in 127 out-of-treatment injection drug users using the HIV Risk Questionnaire (HRQ) across two administration methods: (a) a brief standard quantity-frequency approach covering the past 30 days and (b) a lengthier timeline follow-back (TLFB) procedure for improving recall. The two procedures produced similar frequencies of risk behavior across most items (80%) and good intra- and interclass correlation coefficients. The TLFB, however, resulted in higher frequencies for two risk behavior questions-sharing of any drug injection equipment and having any type of unprotected sex. The TLFB is a well-established procedure for retrospective assessment of HIV risk behavior and a good choice when precision in measuring these behaviors is a primary focus of the work. In contrast, the brief HRQ-Standard interview procedure appears to be a reasonable choice for clinical, research, and health-related surveys where the primary focus is broader than HIV risk behavior.

Download full-text


Available from: Christina S Meade
  • Source
    • "Following the consent process, participants were screened for DSM-IV criteria for opioid, or other substance dependence (SCID; First et al., 1995), clinically assessed with physical and psychiatric evaluations, electrocardiogram, laboratory tests, urine drug tests and Addiction Severity Index (ASI; McLellan et al., 1992, 1980). All participants were also educated, counseled and screened for HIV and Hepatitis C, and completed a Brief HIV Risk Questionnaire (Copersino et al., 2010). A study physician reviewed all the screening information and enrolled participants who were aware of the study design and motivated to participate in this brief 9-week treatment with buprenorphine–naloxone. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Opioid use disorders are considered a serious public health problem among young adults. Current treatment is limited to long-term opioid substitution therapy, with high relapse rates after discontinuation. This study evaluated the co-administration of memantine to brief buprenorphine pharmacotherapy as a treatment alternative. Methods: 13-week double-blind placebo-controlled trial evaluating 80 young adult opioid dependent participants treated with buprenorphine/naloxone 16-4 mg/day and randomized to memantine (15 mg or 30 mg) or placebo. Primary outcomes were a change in the weekly mean proportion of opioid use, and cumulative abstinence rates after rapid buprenorphine discontinuation on week 9. Results: Treatment retention was not significantly different between groups. The memantine 30 mg group was significantly less likely to relapse and to use opioids after buprenorphine discontinuation. Among participants abstinent on week 8, those in the memantine 30 mg group (81.9%) were significantly less likely to relapse after buprenorphine was discontinued compared to the placebo group (30%) (p< 0.025). Also, the memantine 30 mg group had significantly reduced opioid use (mean = 0, SEM ± 0.00) compared to the placebo group (mean = 0.33, SEM ± 0.35; p< 0.004) during the last 2 weeks of study participation. Conclusions: Memantine 30 mg significantly improved short-term treatment with buprenorphine/naloxone for opioid dependent young adults by reducing relapse and opioid use after buprenorphine discontinuation. Combined short-term treatment with buprenorphine/naloxone may be an effective alternative treatment to long-term methadone or buprenorphine maintenance in young adults.
    Full-text · Article · Nov 2015 · Drug and Alcohol Dependence
  • Source
    • "). Information was triangulated across the various data collection methodologies to assess the outcome measures described below. For individual interviews with MAT patients, we used a standardized structured questionnaire that included validated research instruments including the Treatment Perceptions Questionnaire (TPQ) [4], the Drug use and Criminality section of the Opiate Treatment Index (OTI) [5], and the HIV Risk Questionnaire-Short Version [6]. In addition, questions related to patients' overall satisfaction with their own health and their drug-related expenses in the last 30 days were included. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Study Aims. Evaluate the quality and effectiveness of the medication-assisted therapy (MAT) pilot in Kazakhstan and review implementation context and related challenges. Methods. We performed a desk review of MAT policy and program documents and reviewed medical records at three MAT sites in Kazakhstan. MAT patients (n = 93) were interviewed to assess their perceptions of the program and its impact on their health, criminal, drug use, and HIV risk related behaviors as well as expenditures on nonprescribed psychoactive drugs. Persons injecting drugs who are not in treatment, MAT program staff, and other stakeholders were interviewed to obtain their perspectives on MAT. Results. Legislation supports introducing MAT as a standard of care for treatment of opioid dependence; however, its progress has been hampered by active opposition. Inadequate access and coverage, insufficient supply management, scarce infrastructure of narcological facilities, limited opportunities for staff development, and restrictive methadone dispensing policies compromise the quality of the intervention and limit its potential benefits. There were significant reductions in criminal, drug use, and HIV risk related behaviors in patients receiving MAT. Conclusions. The MAT pilot in Kazakhstan demonstrated its feasibility and effectiveness in the local context and is recommended for scaleup throughout the country.
    Full-text · Article · Dec 2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study examines the relationship between criminal justice involvement and high-risk sexual partnerships among a random sample of 416 women in methadone treatment in New York City. Logistic regression models were used to estimate the associations between recent criminal justice involvement (arrest or incarceration in the past 6 months) and recent high-risk partnerships (multiple sex partners, sex trading, or sex with a risky partner in the past 6 months) when adjusting for sociodemographic factors and recent regular drug use. Women with recent criminal justice involvement demonstrated higher odds of engaging in high-risk sex partnerships. Although regular drug use was a significant confounder of several of these relationships, recent arrest or incarceration remained significantly associated with multiple sex partnerships, sex with a risky partner, and engaging in unprotected sex and a high-risk partnership even after controlling for regular drug use and other social stressors. This study highlights the vulnerability of drug-involved women offenders to human immunodeficiency virus (HIV) risk and points to the need for investigation into the role of arrest and incarceration as factors that may contribute to HIV infection.
    Full-text · Article · Mar 2010 · Journal of substance abuse treatment
Show more